Product Information
DANAZOL 50 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.5644 per EA under NDC 00555063302. Its NADAC has been published 75 times since Jan 22, 2025.
Strength
50 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555063302
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
DANAZOLApproval Type
Generic (ANDA)
FDA Application
ANDA074582On Market Since
6/25/1998
Pharmacological Classes
Price Statistics
The NADAC for DANAZOL 50 MG CAPSULE has been published 75 times since Jan 22, 2025, and over the history we have for it it has risen 33.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5644 per EA |
|---|---|
| All-time high | $1.9607 (Feb 11, 2026) |
| All-time low | $1.1711 (Jan 22, 2025) |
| 52-week high | $1.9607 |
| 52-week low | $1.4503 |
| Median price | $1.5644 |
| Average price | $1.5647 |
| Largest weekly change | -20.2% (Feb 18, 2026) |
| Weeks tracked | 75 |
| Tracking since | Jan 22, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DANAZOL 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DANAZOL 50 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $1.5644 per EA (NDC 00555063302), effective Jun 24, 2026.
How has the price of DANAZOL 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DANAZOL 50 MG CAPSULE has risen 33.6%. It has been tracked across 75 weekly CMS publications since Jan 22, 2025.
What are the highest and lowest recorded NADAC prices for DANAZOL 50 MG CAPSULE?
Since Jan 22, 2025, the NADAC for DANAZOL 50 MG CAPSULE has ranged from a low of $1.1711 (Jan 22, 2025) to a high of $1.9607 (Feb 11, 2026), with a median of $1.5644 per EA.
Are there cheaper alternatives to DANAZOL 50 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as DANAZOL 50 MG CAPSULE, but none are currently priced below it.
Who manufactures DANAZOL 50 MG CAPSULE?
DANAZOL 50 MG CAPSULE (NDC 00555063302) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification